Document Detail

Transdermal nicotine in smoking cessation. A meta-analysis.
MedLine Citation:
PMID:  8157037     Owner:  NLM     Status:  MEDLINE    
A systematic search of the literature was made to identify relevant reports of clinical trials of transdermal nicotine, followed by detailed statistical analysis of the results to calculate a pooled estimate of the rate of smoking cessation. Both a fixed effect and a random effects model were used to calculate pooled estimates. The pooled odds ratio (OR) for short-term smoking cessation in favour of the transdermal patches was OR = 3.10. Using a random effects model, the risk difference (RD) in favour of the transdermal patches was RD = 0.25. The corresponding values for long-term cessation were OR = 2.26 and RD = 0.11. Skin irritation was a common adverse effect with incidence rates ranging up to about 70%. Nicotine transdermal patches were effective in promoting smoking cessation both in the short-term, with assessments at 3 to 10 weeks, and in the long-term, with assessment at 24 to 52 weeks. Long-term abstinence rates in subjects treated with nicotine patches for a few weeks remained higher than in subjects treated with placebo patches. Adverse effects were usually minor and transient, although subjects with a sensitive skin may find the applications intolerable. Further studies are required to confirm the value of nicotine patches in promoting smoking cessation in the absence of professional medical support and in general medical practices in the community.
A Li Wan Po
Related Documents :
8261877 - Early smoking initiation and nicotine dependence in a cohort of young adults.
6577217 - Tar yields of cigarettes and male lung cancer risk.
3862617 - Mucociliary clearance and airways obstruction in smokers, ex-smokers and normal subject...
11597117 - Human alveolar long-term clearance of ferromagnetic iron oxide microparticles in health...
16493127 - Physical activity correlates in adolescent girls who differ by weight status.
2275737 - The effects of mandatory seat belt legislation on self-reported seat belt use among mal...
Publication Detail:
Type:  Journal Article; Meta-Analysis    
Journal Detail:
Title:  European journal of clinical pharmacology     Volume:  45     ISSN:  0031-6970     ISO Abbreviation:  Eur. J. Clin. Pharmacol.     Publication Date:  1993  
Date Detail:
Created Date:  1994-05-19     Completed Date:  1994-05-19     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  1256165     Medline TA:  Eur J Clin Pharmacol     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  519-28     Citation Subset:  IM    
Pharmacoepidemiology Section, School of Pharmacy, Queen's University of Belfast, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Cutaneous
Middle Aged
Nicotine / administration & dosage,  adverse effects,  therapeutic use*
Smoking Cessation*
Weight Gain / drug effects
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Efficacy and safety of high dose fluvastatin in patients with familial hypercholesterolaemia.
Next Document:  Plasma levels of piperacillin and vancomycin used as prophylaxis in liver transplant patients.